MedTrace Logo

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1

NCT03306823 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 556

Last updated 2017-10-11

No results posted yet for this study

Summary

In the stage of registration study, our purpose is to find out the safety range of activated coagulation time level in cerebral aneurysm and arteriovenous malformations with hybrid operation.

Conditions

  • Cerebral Aneurysm
  • Arteriovenous Malformations

Sponsors & Collaborators

  • Tang-Du Hospital

    collaborator OTHER

  • Kunming Medical University

    collaborator OTHER

  • First Affiliated Hospital of Fujian Medical University

    collaborator OTHER

  • Nanjing PLA General Hospital

    collaborator OTHER

  • Fujian Medical University Union Hospital

    collaborator OTHER

  • Beijing Tiantan Hospital

    lead OTHER

Eligibility

Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-09-30
Completion
2021-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306823 on ClinicalTrials.gov